Good evening :)
$
₹
Baxter International Inc

Baxter International Inc

BAX

NYSE
Asset Logo

Baxter International Inc

BAX

NYSE
$25.530.44% (-0.11)
$
₹
$25.530.44% (-0.11)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Large Cap

With a market cap of $13.7B the stock is ranked 815

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.02
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.21
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

36.67
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-6.23%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.16%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 15 analysts reports

Buy
2 analysts
Hold
12 analysts
Sell
1 analyst

Price Upside

+1.89%

Earnings Growth

-7.39%

Rev. Growth

+4.07%

See Detailed Forecast

Company Profile

Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
42.94
42.94
1Y Return
7.25%
7.25%
Buy Reco %
82.14
82.14
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
58.29
58.29
1Y Return
12.11%
12.11%
Buy Reco %
76.47
76.47
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.89
38.89
1Y Return
10.7%
10.7%
Buy Reco %
83.33
83.33
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
25.78
25.78
1Y Return
15.97%
15.97%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
36.17
36.17
1Y Return
6.31%
6.31%
Buy Reco %
76.66
76.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 1.89% growth, versus a trailing 3-year CAGR of -6.75%.

2026
Current$26.5Baseline
Analyst Target - 1 year
Target$27+1.89%

All values in $

202220232024202520262027$25.90$34.61$43.31Target+1.89%
2026
Current$26.5Baseline
Analyst Target - 1 year
Target$27+1.89%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 4.07% growth, versus a trailing 3-year CAGR of 3.79%.

2025
Current$11.24Baseline
Forecast for Dec 2026
High$11.73+4.41%
Average$11.70+4.07%
Low$11.62+3.34%

All values in $ Billion

20212022202320242025202612.1410.0510.3610.6311.24Low+3.34%Average+4.07%High+4.41%
2025
Current$11.24Baseline
Forecast for Dec 2026
High$11.73+4.41%
Average$11.70+4.07%
Low$11.62+3.34%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -7.39% growth, versus a trailing 3-year CAGR of -13.44%.

2025
Current$2.27Baseline
Forecast for Dec 2026
High$2.15-5.29%
Average$2.1-7.39%
Low$2.07-8.81%

All values in $

2021202220232024202520263.623.52.72.42.27Low-8.81%Average-7.39%High-5.29%
2025
Current$2.27Baseline
Forecast for Dec 2026
High$2.15-5.29%
Average$2.1-7.39%
Low$2.07-8.81%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

2.9
-1.1
2.7
-0
2.9
0.1
2.9
0.2
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue2.692.692.752.622.812.832.972.702.962.97
Net Income-0.310.14-0.510.120.09-0.04-1.12-0.010.120.29
Net Profit Margin-11.65%5.18%-18.59%4.8%3.23%-1.62%-37.92%-0.55%4.25%9.87%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Baxter International Inc -2.0236.67
Abbott Laboratories42.943.701.56
Intuitive Surgical Inc58.299.742.04
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare BAX with any stock or ETF
Compare BAX with any stock or ETF
Comparing from
BAX
ABT
ISRG
Loading...

Frequently asked questions

  1. Baxter International Inc (BAX) share price today is $25.53 as of November 6, 2026 at 10:18 PM IST. The stock touched a day high of $25.58 and a day low of $24.91.

  2. Baxter International Inc stock trades on NYSE under the ticker symbol BAX.

  3. Baxter International Inc's market capitalization is $13.7B as of November 6, 2026 at 10:18 PM IST.

  4. Baxter International Inc's price-to-earnings (P/E) ratio is N/A as of November 6, 2026.

  5. Baxter International Inc's price-to-book (P/B) ratio is 2.02 as of November 6, 2026.

  6. Yes, Baxter International Inc pays a dividend, with a current dividend yield of 0.16%.

  7. Yes, You can buy Baxter International Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Baxter International Inc shares in three steps: 1. Search Baxter International Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Baxter International Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Baxter International Inc (BAX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.3916 shares at the current price of $25.53.

Loading...